Use of quality-adjusted life year weights with dose-response models for public health decisions: A case study of the risks and benefits of fish consumption

Risk Analysis

Volumn 20, Issue 4, 2000, Pages 529-542

  Ponce, Rafael A ^a   Faustman, Elaine M ^a   Lee, Robert C ^a   Wong, Eva Y ^a   Bartell, Scott M ^a   Bolger, Michael ^b   LaFlamme, Denise ^b   Carrington, Clark ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Washington Department of Ecology   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Fish; Methylmercury; Quality of life; Risk analysis; Risk benefit analysis

Indexed keywords

FISHERIES; FOOD PRODUCTS; TOXICITY;

DOSE-RESPONSE MODELING; QUALITY-ADJUSTED LIFE YEAR WEIGHTS;

HEALTH RISKS;

METHYLMERCURY; TOXIC SUBSTANCE;

DECISION MAKING; FISH; FOOD CONSUMPTION; POLLUTION EXPOSURE; PUBLIC HEALTH;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); DECISION MAKING; DEVELOPMENTAL DISORDER; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; FISH; FOOD ANALYSIS; FOOD INTAKE; HEALTH HAZARD; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NERVOUS SYSTEM DEVELOPMENT; PRENATAL EXPOSURE; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; TECHNIQUE; THEORETICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; DIET; ENVIRONMENTAL EXPOSURE; FEMALE; FISHES; FOOD CONTAMINATION; HEALTH BEHAVIOR; HUMANS; INFANT; MALE; MATERNAL-FETAL EXCHANGE; METHYLMERCURY COMPOUNDS; MIDDLE AGED; MYOCARDIAL INFARCTION; NERVOUS SYSTEM; PREGNANCY; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; WASHINGTON;

EID: 0034581584     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/0272-4332.204050     Document Type: Article

References (83)

1. Balancing fish consumption benefits with mercury exposure
2. Methylmercury and fish consumption: Weighing the risks
3. Prenatal methylmercury exposure and children: Neurologic, developmental and behavioral research
4. Eating fish
5. Outcome measurement in economic evaluation
6. The Qualy approach
7. Quality-adjusted life years: Origins, measurements, applications, objectives
8. Are healthy-years equivalents an improvement over quality-adjusted life years?
9. Methylmercury developmental neurotoxicity: A comparison of effects in humans and animals
10. A review of methylmercury and child development
11. Balancing human exposure, risk and reality: Questions raised by the Canadian aboriginal methylmercury program
12. Mercury in fish
13. Methylmercury and fish - Risks and benefits
14. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
15. Fish consumption and the 30-year risk of fatal myocardial infarction
16. Fish consumption and mortality from all causes, ischemic heart disease, and stroke: An ecological study
17. Fatty acids and antioxidants in the Inuit diet. Their role in ischemic heart disease (IHD) and possible interactions with other dietary factors. A review
18. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: Possible mechanisms
19. Are fish oils beneficial in the prevention and treatment of coronary artery disease?
20. Fish oil, atherogenesis, and thrombogenesis
21. Omega-3 fatty acids in health and disease and in growth and development
22. Breastfeeding for optimal mental development. The alpha and the omega in human milk
23. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men
24. Births: Final data for 1997
25. Estimates of per capita fish consumption in the U.S. based on the Continuing Survey of Food Intake by Individuals (CSFII)
26. Years of healthy life
27. Fetal methylmercury poisoning: Relationship between concentration in single strands of maternal hair and child effects
28. Valuation of quality of life: Some psychometric evidence
29. Probabilistic assessment of health risks of methylmercury from burning coal
30. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases
31. The composition of food consumed by Greenland Eskimos
32. The composition of the Eskimo food in northwestern Greenland
33. The inuit diet. Fatty acids and antioxidants, their role in ischemic heart disease, and exposure to organochlorines and heavy metals. An international study
34. Atherosclerosis in Alaska natives and non-natives
35. n-3 fatty acids in adipose tissue and coronary artery disease are inversly related
36. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest
37. Serum fatty acids and the risk of coronary heart disease
38. Fish consumption and risk of sudden cardiac death
39. Diet, lipids, and coronary heart disease
40. Dietary fats and coronary heart disease
41. Fetal Minamata disease: A neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound
42. Methylmercury poisoning in Iraq
43. Abnormal neuronal migration, deranged cerebral cortical organization, and diffuse white matter astrocytosis of human fetal brain: A major effect of methylmercury poisoning in utero
44. Fetal methylmercury poisoning: Clinical and toxicological data on 29 cases
45. Dose-response relationship for human fetal exposure to methylmercury
46. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men
47. Fish consumption and cardiovascular disease in the Physicians' Health study: A prospective study
48. The effect of fish oil on blood pressure in mild hypertensive subjects: A randomized crossover trial
49. Letter to the editor
50. Fish consumption and mortality from coronary heart disease
51. A risk assessment for methylmercury in tuna
52. Effects of developmental methylmercury exposure or lifetime lead exposure on vibration sensitivity function in monkeys
53. Sensory and cognitive effects of developmental methylmercury exposure in monkeys, and a comparison to effects in rodents
54. Evidence for delayed neurotoxicity produced by methylmercury
55. Neuroloxicology of PCBs and related compounds
56. Developmental neurotoxicity of PCBs in humans: What do we know and where do we go from here?
57. Neurological condition in 42-month-old children in relation to pre- and postnatal exposure to polychlorinated biphenyls and dioxins
58. PCBs, DDE, and child development at 18 and 24 months
59. Dose-response in perinatal exposure to polychlorinated biphenyls (PCBs): The Michigan and North Carolina cohort studies
60. Effects of environmental chemicals on early development
61. Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women
62. A comparison of the early outcome of acute myocardial infarction in women and men
63. Estimating national spending on prevention - United States
64. Identifying and valuing health
65. Cost-effectiveness of strategies to prevent neural tube defects